These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 6660020)

  • 1. [Sézary syndrome].
    Pinto JM; Amaro JA; Porto MT; de Moura MC
    Acta Med Port; 1983; 4(9-10):405-11. PubMed ID: 6660020
    [No Abstract]   [Full Text] [Related]  

  • 2. [Granulomatous Sézary syndrome with epithelial islands].
    Haneke E
    Z Hautkr; 1984 Jul; 59(14):951-61. PubMed ID: 6475173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytochemical and cytogenetic study of a case of Sézary syndrome developing sarcomatous features (author's transl)].
    Grusovin GD; Cavazzini L; Bearzi I
    Haematologica; 1978 Aug; 63(4):454-77. PubMed ID: 100389
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.
    el-Azhary RA; Bouwhuis SA
    Int J Dermatol; 2005 Jan; 44(1):25-8. PubMed ID: 15663654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sézary-Baccaredda syndrome].
    Alonso AM; Balassiano E; Bacha PC
    Med Cutan Ibero Lat Am; 1981; 9(4):303-6. PubMed ID: 7024683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sézary syndrome].
    Betti R; Marchegiani G; Gagliardi P
    Minerva Med; 1982 Apr; 73(15):977-82. PubMed ID: 6210853
    [No Abstract]   [Full Text] [Related]  

  • 7. [Extracorporeal photopheresis in the therapy of Sézary syndrome].
    Marschalkó M; Knobler R; Soós G; Berecz M; Pálóczy K; Rácz I
    Orv Hetil; 1993 Jun; 134(23):1253-7. PubMed ID: 8332344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome.
    Michaelis S; Kazakov DV; Burg G; Dummer R; Kempf W
    Int J Dermatol; 2006 Mar; 45(3):277-9. PubMed ID: 16533228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.
    Bouwhuis SA; el-Azhary RA; McEvoy MT; Gibson LE; Habermann TM; Witzig TE; Pittelkow MR
    Int J Dermatol; 2002 Jun; 41(6):352-6. PubMed ID: 12100691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sézary cells].
    Kozinets GI; Lezvinskaia EM; Persina IS
    Probl Gematol Pereliv Krovi; 1980 Apr; 25(4):44-9. PubMed ID: 6966799
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baccaredda-Sézary syndrome.
    Rebora A; Crovato F; Bertamino R; Nunzi E
    J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):907-8. PubMed ID: 6512046
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
    Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
    Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sézary syndrome showing a stable clinical course for more than four years after oral administration of etoposide and methotrexate].
    Hirayama Y; Nagai T; Ohta H; Koyama R; Matsunaga T; Sakamaki S; Niitsu Y
    Rinsho Ketsueki; 2000 Sep; 41(9):750-4. PubMed ID: 11070938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postcapillary venules in lymph nodes in 3 cases of Sézary syndromes.
    de Diller L; Jautzke G; Gross U
    Ann Pathol; 1982; 2(2):169-72. PubMed ID: 7104071
    [No Abstract]   [Full Text] [Related]  

  • 18. Sezary lineage cells can be induced to proliferate via CD28-mediated costimulation.
    McCusker ME; Garifallou M; Bogen SA
    J Immunol; 1997 May; 158(10):4984-91. PubMed ID: 9144518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
    Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
    Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular kinetics in a patient with Sezary syndrome.
    Chandra PO; Chanana AD; Chikkappa G; Cronkite EP
    Am J Hematol; 1981 Jun; 10(4):327-29. PubMed ID: 6972695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.